Endocrine Abstracts

Gestational diabetes (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy and is associated with increased feto-maternal morbidity as well as long-term complications in mothers and offspring. GDM is diagnosed by an oral glucose tolerance test (OGTT) or overt hyperglycemia. In case of a high risk for GDM or type 2 diabetes measurement of fasting glucose and HbA1c and/or performance of the OGTT (120 min; 75 g glucose) is recommen...

Gestational diabetes affect about 5% of all pregnancies and is associated with increased risk for mother and fetus. It has been shown to be associated with increased risk for preeclampsia, postpartal bleeding, and cesarean section rate as well as intrauterine fetal death, macrosomia, shoulder dystocia, and neonatal hypoglycaemia. Several studies have shown the beneficial effect of tight blood glucose control even in mild gestational diabetes. Diet and insulin treatment are the...

Gestational diabetes mellitus (GDM) is a common condition affecting 2–10% of pregnant women in the USA and in Europe and is associated with adverse outcomes for both the fetus and the mother. Previous GDM is a major risk factor for type 2 diabetes (T2DM), which occurs in 20–60% of affected women within 5 years of the pregnancy1. In studies comparing women with GDM with those with unaffected pregnancies, relative risks for the development of diabetes after ...